Q3 2025 Thermo Fisher Scientific Inc Earnings Call Transcript
Key Points
- Thermo Fisher Scientific Inc (TMO) reported a 5% revenue growth in Q3 2025, reaching $11.12 billion.
- Adjusted operating income increased by 9% to $2.59 billion, with an adjusted EPS growth of 10% to $5.79 per share.
- The company raised its full-year revenue guidance to a range of $44.1 billion to $44.5 billion and adjusted EPS guidance to $22.60 to $22.86 per share.
- Strong performance in the pharma and biotech sectors, particularly in bio-production and analytical instruments.
- Successful strategic collaborations, including a partnership with OpenAI to enhance productivity and innovation.
- Revenue from the academic and government sectors declined in the low single-digits, with similar conditions in the US as in Q2.
- Diagnostics and healthcare revenue growth remained down in the low single-digits, largely due to conditions in China.
- The analytical instruments segment saw a 5% decrease in adjusted operating income, with a 230 basis point decline in adjusted operating margin.
- The company faced headwinds from tariffs and related foreign exchange impacts.
- China's market conditions remained weak, with a mid single-digit decline in revenue, impacting overall growth.
Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 3rd quarter conference call. My name is Claire, and I will be coordinating your call today. During the presentation, you can register a question by pressing star followed by 1 on your telephone keypad.
If you change your mind, please press star followed by 2 on your telephone keypad.
I would like to introduce our moderator for the call, Mr. Rafael Tejada, Vice President, Investor Relations. Mr. Tejada, you may begin the call.
Good morning and thank you for joining us. On the call with me today is Mark Kasper, our Chairman, President and Chief Executive Officer, and Stephen Williamson, senior Vice President and Chief Financial Officer.
Please note this call is being webcast live and will be archived on the investor section of our website, ThermoFisher.com under the heading. News, events and presentations until February 1, 2026. A copy of the press release of our third
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
